Cencora, Inc. (LON:0HF3)
London flag London · Delayed Price · Currency is GBP · Price in USD
286.43
-3.32 (-1.15%)
At close: May 9, 2025

Revenue by Product

Fiscal year is October - September.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Mar '25 Sep '24 Sep '23 Sep '22 Sep '21
US Human Health
-
Log In
Log In
Log In
Log In
US Human Health Growth
-
Log In
Log In
Log In
Log In
US Animal Health
-
Log In
Log In
Log In
Log In
US Animal Health Growth
-
Log In
Log In
Log In
Log In
Other Healthcare Solutions
-
Log In
Log In
Log In
Log In
Other Healthcare Solutions Growth
-
Log In
Log In
Log In
Log In
Total US Healthcare Solutions
281.18B
Log In
Log In
Log In
Log In
Total US Healthcare Solutions Growth
13.24%
Log In
Log In
Log In
Log In
Total International Healthcare Solutions
29.06B
Log In
Log In
Log In
Log In
Total International Healthcare Solutions Growth
2.94%
Log In
Log In
Log In
Log In
International Alliance Healthcare
-
Log In
Log In
Log In
Log In
International Alliance Healthcare Growth
-
Log In
Log In
Log In
Log In

EBIT by Product

Fiscal year is October - September.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Mar '25 Sep '24 Sep '23 Sep '22 Sep '21
Pharmaceutical Distribution Services Segment Operating Income
-
Log In
Log In
Log In
Log In
Pharmaceutical Distribution Services Segment Operating Income Growth
-
Log In
Log In
Log In
Log In
Total Other Segment Operating Income
-
Log In
Log In
Log In
Log In
Total Other Segment Operating Income Growth
-
Log In
Log In
Log In
Log In
US Healthcare Solutions Operating Income
3.20B
Log In
Log In
Log In
Log In
US Healthcare Solutions Operating Income Growth
13.86%
Log In
Log In
Log In
Log In
International Healthcare Solutions Operating Income
674.46M
Log In
Log In
Log In
Log In
International Healthcare Solutions Operating Income Growth
-8.31%
Log In
Log In
Log In
Log In